Document is current

Any future updates will be listed below

Dalteparin as a Novel Therapeutic Agent to Prevent Diabetic Encephalopathy by Targeting Oxidative Stress and Inflammation

Crossref DOI link: https://doi.org/10.32598/bcn.11.6.1775.1

Published Online: 2020-11-01

Update policy: https://doi.org/10.32598/nsp.crossmark-policy

About CrossMark